Richard Pazdur, MD, director of the U.S. Food and Drug Administration’s Oncology Center of Excellence (OCE), joins Lisa Kennedy Sheldon, PhD, APRN, AOCNP®, FAAN, ONS’s clinical and scientific affairs liaison, to discuss oncology nurses’ contributions to cancer care, OCE’s initiatives, and the COVID-19 coronavirus pandemic’s implications for oncology drug approvals.  

Music Credit: "Fireflies and Stardust" by Kevin MacLeod

Licensed under Creative Commons by Attribution 3.0   

Episode Notes 

Check out these resources from today’s episode: 

• FDA new drug approval announcements on ONS Voice
• Richard Pazdur’s biography
• Oncology Center of Excellence
• FDA Guidance on Conduct of Clinical Trials During COVID-19
• FDA Community Outreach and Education Programs
• Project Facilitate
• Project Orbis
• Register for the Mosaic of Oncology Nursing webinar on May 19 from 2–3 pm EST.
• COVID-19 articleson ONS Voice 
• ONS Information Regarding the Coronavirus (COVID-19)
• ONS Interim PPE Guidelines During the COVID-19 Pandemic